Results 201 to 210 of about 83,877 (250)

Expanding Tregs with IVIg

Blood, 2008
In this issue of Blood, Ephrem et al demonstrate that IVIg expands CD4+CD25+FoxP3+ T regulatory cells (Tregs) and enhances their function in vivo and in vitro. Their findings shed new light on the elusive mechanism of action of IVIg in ameliorating autoimmune diseases.
openaire   +1 more source

Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm

Clinical and Experimental Medicine (Testo stampato), 2019
Yue Wu, Fei Liu, Yao Xu, J. Wang, Sama Samadli, Y. Wu, H. Liu, Wei Xia Chen, Huang Huang Luo, D. Zhang, Wei Wei, P. Hu   +11 more
semanticscholar   +1 more source

[Intravenous immunoglobulin (IVIG)].

Nihon rinsho. Japanese journal of clinical medicine, 2009
Intravenous immunoglobulin (VIG) was given by Imbach in 1981 to idiopathic thrombocytopenic purpura (ITP). The cure of many of the patients in response to the IVIG expanded the use of IVIG to other autoimmune condition. The diseases proven the efficacy of VIG by controlled trial were ITP, Guillain-Barré syndrome, chronic inflammatory demyelinating ...
openaire   +1 more source

Intravenous Immunoglobulin (IVIG)

Obstetrics & Gynecology, 2007
openaire   +2 more sources

IVIG

2012
G. Citerio, C. Giussani, Hugo Sax, Didier Pittet, Xiaoyan Wen, John A. Kellum, Angela M. Mills, Nova L. Panebianco, Stuart M. Flechner, Jean Carlet, Andie S. Lee, Stephan Jürgen Harbarth, Jason Ferries, Christian Sandrock, Daniel Scheurich, Hilary M. Babcock, Katherine Mandell, Gregory J. Jurkovich, Clay Cothren Burlew, Ernest E. Moore, Philip F. Stahel, Michael A. Flierl, Christoph E. Heyde, L. D. Britt, Howard R. Champion, Russ Hewson, Rupert M. Pearse, Martin Damm, Marcelo Gama de Abreu, Kevin W. Finkel, Manu L. N. G. Malbrain, Lewis J. Kaplan, J. Claude Hemphill, Jacob Freeman, Andrew M. Bauer, Daniel K. Resnick, Thomas Luecke, Jonathan I. Fischer, Anthony J. Dean, Christiane S. Hartog, Konrad Reinhart, Ryan P. Morrissey, Lewis S. Nelson   +42 more
openaire   +1 more source

Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

EClinicalMedicine, 2021
Shaukat Ali, Muneeba Ahsan Sayeed, Abdur Rasheed   +2 more
exaly  

IVIG

2020
openaire   +1 more source

IVIG Revisited

2007
SP Yadav, Anupam Sachdeva, Ruchira Misra
openaire   +1 more source

TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.

Clinica chimica acta; international journal of clinical chemistry, 2017
P. Hu, G. Jiang, Yuehua Wu, B. Huang, S. Liu, D. Zhang, Yao Xu, Y. Wu, Xun Xia, Wei Wei, Bo Hu   +10 more
semanticscholar   +1 more source

Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial.

Immunology Letters, 2017
M. Ahmadi, Sanaz Abbaspour Aghdam, M. Nouri, Z. Babaloo, L. Farzadi, Aliyeh Ghasemzadeh, K. Hamdi, A. Movassaghpour, F. Jadidi‐Niaragh, Amir Afkham, M. Motallebnezhad, Shadi Eghbal-Fard, S. Dolati, V. Younesi, M. Yousefi   +14 more
semanticscholar   +1 more source